Ernexa Therapeutics Inc. (ERNA) Net Equity Issued and Repurchased (2014 - 2026)
Ernexa Therapeutics' (ERNA) quarterly Net Equity Issued and Repurchased came in at $10.5 million in Q1 2026, up 852.73% on a QoQ basis from $1.1 million in Q3 2024.
Ernexa Therapeutics Inc. (ERNA) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNA) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $10.5 million in Q1 2026.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.6 million (changed N/A YoY) and the FY2025 annual result came in at $4.9 million, up 333.51% from the prior year.
- Net Equity Issued and Repurchased advanced to $10.5 million in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $12.0 million in Q1 2022 to a low of $1.1 million in Q3 2024.
- A 3-year average of $7.8 million and a median of $9.1 million in 2022 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.48 Mn |
| Mar 31, 2026 | 10.48 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Dec 31, 2022 | 7.71 Mn |
| Dec 31, 2022 | 7.71 Mn |
| Mar 31, 2022 | 11.99 Mn |
| Mar 31, 2022 | 11.99 Mn |
| Sep 30, 2021 | 20.00 Mn |
| Sep 30, 2021 | 20.00 Mn |
| Jun 30, 2021 | 20.00 Mn |
| Jun 30, 2021 | 20.00 Mn |
| Jun 30, 2017 | 219,000.00 |
| Jun 30, 2017 | 219,000.00 |
| Mar 31, 2017 | 1.55 Mn |
| Mar 31, 2017 | 1.55 Mn |
| Jun 30, 2014 | -651,750.00 |
| Jun 30, 2014 | -651,750.00 |